DTTC with Caregiver Training for Childhood Apraxia of Speech
(DTTC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different caregiver training methods impact the effectiveness of speech therapy for children with childhood apraxia of speech (CAS). All participating children will receive Dynamic Temporal and Tactile Cueing (DTTC) therapy twice a week. Caregivers will either receive detailed coaching for home practice or general guidance. The study seeks children who primarily speak English, have been diagnosed with CAS, and do not have other developmental disorders such as autism or Down syndrome. As an unphased trial, it offers a unique opportunity to contribute to understanding and improving speech therapy methods for children with CAS.
Will I have to stop taking my current medications?
The trial does not specify whether participants need to stop taking their current medications. However, children with ADHD can participate if they can attend sessions with medication and/or strategies.
What prior data suggests that Dynamic Temporal and Tactile Cueing (DTTC) is safe for children with childhood apraxia of speech?
Research has shown that Dynamic Temporal and Tactile Cueing (DTTC) is a well-tolerated treatment for children with childhood apraxia of speech (CAS). A review of DTTC treatment results found no serious side effects in young children, indicating that DTTC is generally safe for children with CAS. Additionally, DTTC has been widely studied, and consistent findings across many studies support its safety. Current research considers DTTC safe, offering reassurance to parents and caregivers.12345
Why are researchers excited about this trial?
Researchers are excited about the Dynamic Temporal and Tactile Cueing (DTTC) technique for Childhood Apraxia of Speech because it offers a unique approach by actively involving caregivers in the therapy process. Unlike traditional speech therapy that primarily relies on sessions with a speech-language pathologist (SLP), DTTC incorporates both direct and indirect training methods. In the direct training arm, caregivers are coached to administer the treatment at home, providing more consistent and frequent practice. This hands-on involvement can potentially lead to more rapid and sustained improvements in children's speech. By empowering caregivers with the skills and knowledge to support therapy, DTTC aims to enhance the effectiveness of treatment and foster a supportive home environment for speech development.
What evidence suggests that this trial's treatments could be effective for childhood apraxia of speech?
Research has shown that Dynamic Temporal and Tactile Cueing (DTTC) holds promise for children with childhood apraxia of speech (CAS). Studies have found that DTTC can help children speak more clearly and improve their speech-related motor skills. In this trial, participants will be divided into two groups to receive DTTC treatment. In the Direct Training Arm, children will receive DTTC treatment with both a speech-language pathologist (SLP) and their parent/caregiver, who will be coached online by the SLP. In the Indirect Training Arm, children will receive DTTC treatment administered solely by an SLP. Early results suggest that regular use of DTTC leads to noticeable progress in speech development, and it is becoming recognized as an effective way to treat CAS.23678
Are You a Good Fit for This Trial?
This trial is for children aged between 2 years and 5 months to 7 years and 11 months with a primary diagnosis of Childhood Apraxia of Speech (CAS) who speak English as their main language. Kids with autism, global developmental delay, Down syndrome, or severe hearing or visual impairments can't join. Those already receiving speech treatment elsewhere are also excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Treatment
Caregivers complete an online self-guided educational module about CAS and DTTC
Treatment
Participants receive DTTC treatment 2x/week for 8 weeks with home practice 3x/week
Follow-up
Home practice continues at a higher frequency (6x/week) to monitor treatment outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Dynamic Temporal and Tactile Cueing (DTTC)
Dynamic Temporal and Tactile Cueing (DTTC) is already approved in United States, Canada, European Union for the following indications:
- Childhood Apraxia of Speech (CAS)
- Childhood Apraxia of Speech (CAS)
- Childhood Apraxia of Speech (CAS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York University
Lead Sponsor
Hofstra University
Collaborator